What amount sold does INOVISE MEDICAL INC report in Form D filings?

The latest linked filings report $5.8M sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was INOVISE MEDICAL INC's most recent SEC filing?

INOVISE MEDICAL INC's most recent Form D filing was on 2012-09-06.

How many investors does INOVISE MEDICAL INC have?

The most recent Form D filing lists 5 investor(s).

What type of securities does INOVISE MEDICAL INC offer?

INOVISE MEDICAL INC's SEC Form D filings indicate equity offerings.

INOVISE MEDICAL INC

CIK: 0001120221·Other Technology·BEAVERTON, OR·Corporation

Reported Sold

$5,779,233

Total Filings

Identified Offerings

Last Filed

Sep 6, 2012

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Technology industry

SEC EDGAR

Offering filing timeline

Sep 6, 2012Form D — New notice

Reported sold: $449,512 · Target: $4,200,000

Rule 506·5 investors

Feb 16, 2011Form D — New notice

Reported sold: $4,409,721 · Target: $5,000,000

Rule 506·3 investors

Jul 9, 2009Form D — New notice

Reported sold: $920,000 · Target: $4,000,000

Rule 506·1 investor

Fundraising Profile

Exemptions

Rule 506

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 3 identified offerings

$5,779,233

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Peter Bauer

Related Person

Appears on 1 filing

David Chazanovitz

Related Person

Appears on 1 filing

Dallas Ross

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 6, 2012	New	$4,200,000	$449,512	5
Feb 16, 2011	New	$5,000,000	$4,409,721	3
Jul 9, 2009	New	$4,000,000	$920,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Araceli Biosciences Inc.

Other Technology

Offering target: $4,500,000

Filed Nov 3, 2026